Hindustan Unilever
Broadest lever on the volume recovery
- Last close
- ₹1,863.80
- 29 Sept 2026 · reference
- 1D · 1M
- −1.7% · −7.3%
- price-only
- Weight
- 3.3%
- 31 Jul 2026 · Aug rank 9
- Thesis review
- 8 Sep 2026
- Why We Own, p32
Broadest lever on the volume recovery — what has to happen, what we believe, what breaks it
- Q2FY27 results (late Oct-2026): first quarter fully lapping GST 2.0 base effects; watch for UVG holding at 5%+ and margin recovery from pricing actions.
- Kwality Wall's open offer by Magnum Ice Cream Co consortium (26% of voting capital) post 16-Feb-2026 listing - completion cleans up HUL's portfolio narrative.
- Festive-season demand (Oct-Nov 2026) supported by state cash transfers and lower GST; interim dividend typically announced with Q2 results.
- Volume inflection: underlying volume growth rose from 2-4% through FY25-H1FY26 to 6% in Q4FY26 and 5% in Q1FY27 with USG of 10%, the best in 13 quarters (HUL Q1FY27 release via Business Standard 28-Jul-2026).
- Portfolio reshaped for growth: Home Care +14% and Beauty & Wellbeing +12% USG in Q1FY27; ice cream (low-margin) demerged in Feb-2026; Rs 2,000 cr capex for capacity (ICICI Direct May-2026).
- Cash machine: almost debt-free (borrowings Rs 1,478 cr vs equity ~Rs 48,700 cr), 92% dividend payout, FY26 dividend Rs 41/share (Rs 19 interim + Rs 22 final, total payout Rs 9,633 cr), 2.1% yield.
- Valuation at the low end of its own range: ~42x FY27E ICICI Direct EPS and 9.5x book vs Nestle India at 73x trailing; consensus targets Rs 2,460-2,800 imply 25-43% upside from Rs 1,960.
- Macro tailwinds: GST 2.0 (22-Sep-2025) cut toothpaste, soaps, shampoos and many foods from 18%/12% to 5% (~60% of FMCG basket repriced per NIQ) and ~Rs 1.7 lakh cr/yr of state cash transfers to ~120 mn women support mass-market demand.
- Core · Large cap3.3% of PMS · rank 9
- Commodity inflation: 8-10% material cost inflation in Q1FY27 (palm oil, crude derivatives) with management expecting 2-5% sequential inflation and only 'calibrated' pricing - EBITDA margin risk to the 22.7% FY27E.
- Personal Care (largest legacy segment) grew only 4% USG in Q1FY27 and is losing share to small/regional players that NIQ shows outgrowing large manufacturers.
- Structural growth ceiling: 5-yr sales CAGR only 6.5% (screener); at 42x forward PE, any slippage back to low-single-digit volumes drives further de-rating (stock already -13% from May-26 levels).
Thesis and position rationale
- Investment case
- Broadest lever on the volume recovery
- Why this business
India's largest FMCG company (Unilever subsidiary) selling home care (Surf, Rin, Vim), beauty & wellbeing (Dove, Lakme, Ponds), personal care (Lifebuoy, Lux, Closeup) and foods (Horlicks, Kissan, Knorr, Bru) through ~9 million retail outlets. FY26 consolidated revenue was Rs 64,468 cr with 23-24% EBITDA margin; the ice-cream business (Kwality Wall's) was demerged and listed separately on 16-Feb-2026. Market-share leadership in most categories it operates in (company claims ~9 of 10 Indian households use an HUL brand); exact category shares not disclosed in sources used.
- What we believe
- 01Volume inflection: underlying volume growth rose from 2-4% through FY25-H1FY26 to 6% in Q4FY26 and 5% in Q1FY27 with USG of 10%, the best in 13 quarters (HUL Q1FY27 release via Business Standard 28-Jul-2026).
- 02Portfolio reshaped for growth: Home Care +14% and Beauty & Wellbeing +12% USG in Q1FY27; ice cream (low-margin) demerged in Feb-2026; Rs 2,000 cr capex for capacity (ICICI Direct May-2026).
- 03Cash machine: almost debt-free (borrowings Rs 1,478 cr vs equity ~Rs 48,700 cr), 92% dividend payout, FY26 dividend Rs 41/share (Rs 19 interim + Rs 22 final, total payout Rs 9,633 cr), 2.1% yield.
- 04Valuation at the low end of its own range: ~42x FY27E ICICI Direct EPS and 9.5x book vs Nestle India at 73x trailing; consensus targets Rs 2,460-2,800 imply 25-43% upside from Rs 1,960.
- 05Macro tailwinds: GST 2.0 (22-Sep-2025) cut toothpaste, soaps, shampoos and many foods from 18%/12% to 5% (~60% of FMCG basket repriced per NIQ) and ~Rs 1.7 lakh cr/yr of state cash transfers to ~120 mn women support mass-market demand.
- Why now
Stock at Rs 1,960 has de-rated from ~Rs 2,250 (May-26) after the Q1FY27 miss; ICICI Direct values at 46x FY28E vs current ~42x FY27E / ~36x FY28E on its numbers - below the ~50-60x forward PE HUL commanded in 2020-22 (5-yr average not sourced; treat as qualitative). EV/EBITDA 30.1x; dividend yield 2.1%.
- Market disagreement
- Nestle India: Nestle trades at 72.7x trailing PE (mcap Rs 2.70 lakh cr) vs HUL 41.8x; Nestle's 74% ROE is superior but HUL offers 2.1% dividend yield vs 0.9% and a broader, less milk-price-exposed portfolio.
- ITC: ITC is cheaper (16.7x PE, 5.5% yield) but Jun-26 quarter sales fell 10.9% YoY and 3-yr sales CAGR is 4%; tobacco regulatory overhang and hotels demerger make it a value/yield play rather than a volume-growth compounder.
- Dabur: Dabur is cheaper at 33.7x but 3-yr sales/profit CAGR is only 5%/4% with ROE of 17% vs HUL's ~21-24% (3-yr avg) and Q1FY27 double-digit USG.
- Position sizing
Core Large cap 3.3% of the PMS on $31 Jul 2026 (August rank 9). Core positions are owned through the cycle for leadership and cash-flow quality.
- Catalysts
- Q2FY27 results (late Oct-2026): first quarter fully lapping GST 2.0 base effects; watch for UVG holding at 5%+ and margin recovery from pricing actions.
- Kwality Wall's open offer by Magnum Ice Cream Co consortium (26% of voting capital) post 16-Feb-2026 listing - completion cleans up HUL's portfolio narrative.
- Festive-season demand (Oct-Nov 2026) supported by state cash transfers and lower GST; interim dividend typically announced with Q2 results.
- Risks and response
- Commodity inflation: 8-10% material cost inflation in Q1FY27 (palm oil, crude derivatives) with management expecting 2-5% sequential inflation and only 'calibrated' pricing - EBITDA margin risk to the 22.7% FY27E.
- Personal Care (largest legacy segment) grew only 4% USG in Q1FY27 and is losing share to small/regional players that NIQ shows outgrowing large manufacturers.
- Structural growth ceiling: 5-yr sales CAGR only 6.5% (screener); at 42x forward PE, any slippage back to low-single-digit volumes drives further de-rating (stock already -13% from May-26 levels).
- Thesis-break conditions
- Not stated separately on this page; the risk list carries the monitoring triggers.
- Review history
- 8 Sep 2026 · Yash Palod · one-pager in "Why We Own What We Own" (p32) · portfolio as of $31 Jul 2026
- 31 Aug 2026 · Classification in the August top-30: Core
Source: Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026), p32. Internal; external publication of these fields is controlled by audience policy.
Internal actions
- HoldPosition carried into August at rank 9.
- ReviewNext scheduled: post 2QFY27 results (Oct–Nov 2026).
Add/trim/exit decisions require transactions data; none supplied. Recording a decision needs a persistence adapter (not configured).
Sector datapoints
- NIQ: FMCG value growth 7.8% in Oct-Dec 2025 (down from 12.9% in Jul-Sep 2025) with rural volume +2.9% and urban +2.3%; HPC volume +1.9%, food +2.8% - the GST 2.0 transition disrupted traditional trade for a quarter (NIQ Q4-2025 report, Mar-2026).
- GST 2.0 effective 22-Sep-2025 moved toothpaste, toothpowder, soaps/personal wash and biscuits to 5% (from 18%/12%); nearly 60% of the FMCG portfolio saw rate revisions (NIQ) - benefit expected to show from the Mar-2026 quarter onwards.
- State women-centric cash transfers: 15+ states, ~120 million beneficiaries, ~Rs 1.7 lakh crore/yr in FY26 (Economic Survey 2026 via Down To Earth; Business Standard 17-Jul-2026); Maharashtra Ladki Bahin study shows marginal propensity to consume ~0.9.
- Rural outpaced urban for 7 consecutive quarters to Sep-2025 (rural vol +7.7% vs urban +3.7% in Jul-Sep 2025, NIQ); urban-rural gap narrowed to 2.9% vs 2.3% in Oct-Dec 2025.